in this randomized trial of 463 postmenopausal women 65 years of age or younger with axillary node metastases , treatment with the combination of cmf plus low-dose prednisone and tamoxifen ( cmfp + t ) , was compared to endocrine therapy alone ( p + t ) or to no further treatment after total mastectomy and axillary clearance .
C0032952
prednisone
C0055985
cmfp